Danish national registry data suggest adults with type 2 diabetes taking SGLT2 inhibitors have a slightly lower risk of developing diabetic foot problems than those taking GLP-1 receptor agonists.

You can't hold back time, but scientists believe they may finally be able to slow down ageing. In a revolutionary new field, they are testing drugs to help people live healthier - for longer.

Researchers conducted a cohort study to assess the effect of incretin receptor agonist therapy on continuous positive airway pressure use in T2D, obesity, and OSA.

This opens the door to making mistakes—ones that could worsen your side effects, affect how much weight you’ll lose, or even ...

As GLP-1 pills for weight loss enter the U.S. market, some pharmaceutical companies are testing the possibility of a gene therapy to stimulate GLP-1 production, The Washington Post reported Jan. 24.

A once-weekly injectable glucose-dependent insulinotropic polypeptide/GLP-1 dual agonist conferred up to 14.7% weight loss at ...

However, not everyone is willing—or able—to indefinitely commit to GLP-1s.

Higher-income households with at least one user of GLP-1 class of weight loss drugs cut their grocery spending by nearly 9%, a recent study based on data from the market research firm Numerator ...

Company expands its ADC pipeline and patent estate for novel, differentiated ADCsNew pipeline candidate AKTX-102 leverages ...

Aviva Bio received FDA guidance on women’s testosterone and reported new data showing AVA-291’s markedly reduced breast cancer cell proliferation.

As GLP-1 drugs become more available, some people might use them despite not having excess weight.

An estimated 60% of patients with Alzheimer's disease develop epilepsy or subclinical epileptiform activity over the course of the disease. New-onset seizures in cognitively healthy adults also ...